Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...

A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...

While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...

The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...

Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...

A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in...

Recent study results indicated that pediatric patients with acute lymphoblastic leukemia (ALL) were experiencing some motor skill impacts...

It may seem unusual to discuss future fertility when a family is reeling from the diagnosis of a child’s cancer. But 85% of children with...

Among pediatric patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT), using...